{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:52:24Z","timestamp":1776091944575,"version":"3.50.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Erdheim\u2013Chester disease (ECD) is a rare condition with underestimated neurological involvement. Mild psychiatric symptoms such as mood swings have been rarely described in the clinical spectrum of neuro-ECD. We here describe the first patient with psychiatric manifestations of delirium revealing ECD with neurological involvement with favorable evolution under interferon followed by BRAF inhibitor monotherapy. An 81-year-old woman was referred to the hospital because of delirium and severe cognitive impairment associated with a cerebellar syndrome. Brain magnetic resonance imaging showed \u201cFLAIR-changes\u201d lesions in the pons and upper cerebellum peduncles. Blood and cerebrospinal fluid (CSF) analyses showed normal results except for an elevated neopterin level in the CSF. Whole-body CT scan (<jats:sup>18<\/jats:sup>FDG-PET) showed peri-nephric fat infiltration and aorta adventitia sheathing with radiotracer uptake in the pons, vessels, peri-nephric fat, and bone lesions, which was characteristic of ECD. The diagnosis was confirmed on perirenal tissue biopsy, which also showed a <jats:italic>BRAF<jats:sup>V600E<\/jats:sup><\/jats:italic> mutation. Treatment with interferon resulted in the resolution of delirium, and treatment with BRAF inhibitor subsequently resulted in a partial remission of all active sites. This case highlights that delirium can be the first manifestation of neurodegenerative ECD. ECD should be screened in unexplained psychiatric features as interferon and targeted therapy appear to be effective in this situation.<\/jats:p>","DOI":"10.3389\/fimmu.2022.918613","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:22:02Z","timestamp":1657128122000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAFV600E-Mutated Erdheim\u2013Chester Disease: A Case Report"],"prefix":"10.3389","volume":"13","author":[{"given":"J\u00e9r\u00f4me","family":"Razanamahery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maroua","family":"Abdallahoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Chabridon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Fromont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Tarris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Idbaih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre Olivier","family":"Comby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Godard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Haroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Audia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Bonnotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003507","article-title":"Erdheim-Chester Disease: Consensus Recommendations for the Evaluation, Diagnosis, and Treatment in the Molecular Era","volume":"2020135","author":"Goyal","year":"","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab107","article-title":"Histiocytosis and the Nervous System: From Diagnosis to Targeted Therapies","volume":"23","author":"Cohen Aubart","year":"2021","journal-title":"Neuro Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30373-3","article-title":"Neurodegeneration in Histiocytoses Might Start In Utero","volume":"16","author":"Haroche","year":"2017","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010748","article-title":"Central Nervous System Involvement in Erdheim-Chester Disease: An Observational Cohort Study","author":"Aubart","year":"2020","journal-title":"Neurol Epub"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa008","article-title":"Neurologic and Oncologic Features of Erdheim-Chester Disease: A 30-Patient Series","volume":"22","author":"Bhatia","year":"2020","journal-title":"Neuro-oncology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/acn3.51014","article-title":"Neurological Manifestations of Erdheim-Chester Disease","volume":"7","author":"Boyd","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25055","article-title":"Phenotypes and Survival in Erdheim-Chester Disease: Results From a 165-Patient Cohort","volume":"93","author":"Cohen-Aubart","year":"2018","journal-title":"Am J Hematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discovery"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.2460","article-title":"Longitudinally Extensive Spinal Cord Lesion in Erdheim-Chester Disease","volume":"77","author":"Simpson","year":"2020","journal-title":"JAMA Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018030502","article-title":"A Scale for Patient-Reported Symptom Assessment for Patients With Erdheim-Chester Disease","volume":"3","author":"Diamond","year":"2019","journal-title":"Blood Adv"},{"key":"B11","unstructured":"CNS Langerhans Cell Histiocytosis: Common Hematopoietic Origin for LCH-Associated Neurodegeneration and Mass Lesions: Hematopoietic Origin of LCH-Nd\n            McClainKL\n            PicarsicJ\n            ChakrabortyR\n          2018"},{"key":"B12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13023-022-02220-0","article-title":"Rosai-Dorfman-Destombes Disease of the Nervous System: A Systematic Literature Review","volume":"17","author":"Nasany","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-839753","article-title":"Consensus Recommendations for the Diagnosis and Clinical Management of Rosai-Dorfman-Destombes Disease","volume":"131","author":"Abla","year":"2018","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nature23672","article-title":"A Somatic Mutation in Erythro-Myeloid Progenitors Causes Neurodegenerative Disease","volume":"549","author":"Mass","year":"2017","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.16.3.367","article-title":"Disorders of the Cerebellum: Ataxia, Dysmetria of Thought, and the Cerebellar Cognitive Affective Syndrome","volume":"16","author":"Schmahmann","year":"2004","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"18291","DOI":"10.1038\/s41598-020-75500-z","article-title":"Cerebrospinal Fluid Neopterin as a Biomarker of Neuroinflammatory Diseases","volume":"10","author":"Molero-Luis","year":"2020","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852919000981","article-title":"Cerebrospinal Fluid Biomarkers in Patients With Central Nervous System Infections: A Retrospective Study","volume":"25","author":"Di Stefano","year":"2020","journal-title":"CNS Spectr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-0186(99)00031-5","article-title":"Unchanged Levels of Interleukins, Neopterin, Interferon-Gamma and Tumor Necrosis Factor-Alpha in Cerebrospinal Fluid of Patients With Dementia of the Alzheimer Type","volume":"34","author":"Engelborghs","year":"1999","journal-title":"Neurochem Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2015.10.003","article-title":"Neopterin as a Potential Cytoprotective Brain Molecule","volume":"71","author":"Ghisoni","year":"2015","journal-title":"J Psychiatr Res"},{"key":"B20","unstructured":"Serum Neopterin Levels as a Diagnostic Marker of Hemophagocytic Lymphohistiocytosis Syndrome\n            IbarraMF\n            Klein-GitelmanM\n            MorganE\n          2011"},{"key":"B21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13023-016-0490-3","article-title":"Diffuse Reduction of Cerebral Grey Matter Volumes in Erdheim-Chester Disease","volume":"11","author":"Diamond","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/0004867418807299","article-title":"Reduced Cortical Thickness in Subjects at Clinical High Risk for Psychosis and Clinical Attributes","volume":"53","author":"Kwak","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-771873","article-title":"Targeted Therapies in 54 Patients With Erdheim-Chester Disease, Including Follow-Up After Interruption (the LOVE Study)","volume":"130","author":"Cohen Aubart","year":"2017","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.918613\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:22:05Z","timestamp":1657128125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.918613\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2022.918613"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.918613","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"article-number":"918613"}}